Article
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi.
Antimicrobial agents and chemotherapy - 1 Feb 2006
Criswell Daniel, Tobiason Virginia L, Lodmell J Stephen, Samuels D Scott
Abstract excerpt
We have isolated and characterized in vitro mutants of the Lyme disease agent Borrelia burgdorferi that are resistant to spectinomycin, kanamycin, gentamicin, or streptomycin, antibiotics that target the small subunit of the ribosome. 16S rRNA mutations A1185G and C1186U, homologous to Escherichia coli nucleotides A1191 and C1192, conferred >2,200-fold and 1,300-fold resistance to spectinomycin, respectively. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
